{"organizations": [], "uuid": "5f99119bdad1442ed4e34148c66bca95f11d29a3", "thread": {"social": {"gplus": {"shares": 0}, "pinterest": {"shares": 0}, "vk": {"shares": 0}, "linkedin": {"shares": 0}, "facebook": {"likes": 0, "shares": 0, "comments": 0}, "stumbledupon": {"shares": 0}}, "site_full": "www.reuters.com", "main_image": "https://s4.reutersmedia.net/resources_v2/images/rcom-default.png", "site_section": "http://www.reuters.com/resources/archive/us/20180417.html", "section_title": "Archive News &amp; Video for Tuesday, 17 Apr 2018 | Reuters.com", "url": "https://www.reuters.com/article/usa-justice-dea-opioids/u-s-drug-agency-to-propose-rules-to-rein-in-opioid-manufacturing-idUSL1N1RU1HO", "country": "US", "domain_rank": 408, "title": "U.S. drug agency to propose rules to rein in opioid manufacturing", "performance_score": 0, "site": "reuters.com", "participants_count": 1, "title_full": "", "spam_score": 0.0, "site_type": "news", "published": "2018-04-18T02:00:00.000+03:00", "replies_count": 0, "uuid": "5f99119bdad1442ed4e34148c66bca95f11d29a3"}, "author": "Sarah N. Lynch", "url": "https://www.reuters.com/article/usa-justice-dea-opioids/u-s-drug-agency-to-propose-rules-to-rein-in-opioid-manufacturing-idUSL1N1RU1HO", "ord_in_thread": 0, "title": "U.S. drug agency to propose rules to rein in opioid manufacturing", "locations": [], "entities": {"persons": [{"name": "jeff sessions", "sentiment": "none"}, {"name": "sarah n. lynch", "sentiment": "none"}], "locations": [{"name": "u.s.", "sentiment": "none"}, {"name": "washington", "sentiment": "none"}, {"name": "united states", "sentiment": "none"}], "organizations": [{"name": "reuters", "sentiment": "negative"}, {"name": "u.s. drug enforcement administration", "sentiment": "negative"}, {"name": "dea", "sentiment": "none"}, {"name": "g crosse", "sentiment": "none"}]}, "highlightText": "", "language": "english", "persons": [], "text": "WASHINGTON, April 17 (Reuters) - The U.S. Drug Enforcement Administration on Tuesday unveiled plans to rein in the amount of opioids that can be manufactured by drug makers in a given year, in an effort to combat the deadly opioid epidemic that has plagued the United States.\nThe DEAâ€™s proposed changes to its regulations over addictive drug manufacturing quotas are expected to be formally announced by Attorney General Jeff Sessions in a speech on Tuesday. (Reporting by Sarah N. Lynch, editing by G Crosse)\n ", "external_links": ["https://twitter.com/reuters", "https://www.youtube.com/user/ReutersVideo", "https://www.linkedin.com/company/10256858/", "https://www.facebook.com/Reuters", "https://www.thomsonreuters.com/en/privacy-statement.html", "http://thomsonreuters.com/en/about-us/trust-principles.html", "https://instagram.com/reuters/"], "published": "2018-04-18T02:00:00.000+03:00", "crawled": "2018-04-18T18:24:51.009+03:00", "highlightTitle": ""}